Skip to main content

Search Videos and More

Showing 1 - 16 of 132 results

Previous| 1 | 2 | 3 ...9 |Next

Mount Sinai Fuster Heart Hospital 2025

Mount Sinai Fuster Heart Hospital 2025

Message From the Director

Message From the Director

Trial Is Comparing Effectiveness of CABG and PCI in Underrepresented Groups and Women

Trial Is Comparing Effectiveness of CABG and PCI in Underrepresented Groups and Women

Landmark Study Identifies a Gene-Regulatory Network That Drives Fibromuscular Dysplasia

Landmark Study Identifies a Gene-Regulatory Network That Drives Fibromuscular Dysplasia

Pulsed Field Ablation Found Safe and Effective for Atrial Fibrillation Patients in International Trial

Pulsed Field Ablation Found Safe and Effective for Atrial Fibrillation Patients in International Trial

Groundbreaking Study of Women Undergoing TAVR Finds Advantages for Self-Expanding Valve

Groundbreaking Study of Women Undergoing TAVR Finds Advantages for Self-Expanding Valve

Research Roundup: Cardiovascular Research Institute Made Significant Findings in Sleep, FMD, and Genomics

Research Roundup: Cardiovascular Research Institute Made Significant Findings in Sleep, FMD, and Genomics

After Myocardial Infarction, the Heart Signals to the Brain to Increase Sleep and Promote Healing

After Myocardial Infarction, the Heart Signals to the Brain to Increase Sleep and Promote Healing

Mount Sinai Develops Algorithm to Optimize Coronary Calcium Management in PCI

Mount Sinai Develops Algorithm to Optimize Coronary Calcium Management in PCI

Mount Sinai Shifts Standard of Treatment for Severe Tricuspid Regurgitation With New, Nonsurgical Options

Mount Sinai Shifts Standard of Treatment for Severe Tricuspid Regurgitation With New, Nonsurgical Options

Hidden Genetic Causes of Congenital Heart Disease Identified

Hidden Genetic Causes of Congenital Heart Disease Identified

Study led by Mount Sinai Researcher shows Sotagliflozin is the Only Drug in its class to Significantly Reduce Both Heart Attacks and Strokes

Study led by Mount Sinai Researcher shows Sotagliflozin is the Only Drug in its class to Significantly Reduce Both Heart Attacks and Strokes

Changing the Cardiovascular Risk Profile for Women With Severe or Early Preeclampsia

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

PRECAD Trial to Explore If Controlling Risk Factors at Early Age Can Prevent Cardiovascular Events in Later Life

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

Stopping Aspirin One Month After PCI Is Found Safe in Patients With Acute Coronary Syndromes

Showing 1 - 16 of 132 results

Previous| 1 | 2 | 3 ...9 |Next